Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -85.23% |
| Q3 2025 | -41.44% |
| Q2 2025 | -33.64% |
| Q1 2025 | -82.76% |
| Q4 2024 | 7.82% |
| Q3 2024 | -8.21% |
| Q2 2024 | -24.87% |
| Q1 2024 | -9.07% |
| Q4 2023 | -11.59% |
| Q3 2023 | 16.35% |
| Q2 2023 | -9.98% |
| Q1 2023 | 14.93% |
| Q4 2022 | -10.61% |
| Q3 2022 | -8.36% |
| Q2 2022 | -8.92% |
| Q1 2022 | -8.48% |
| Q4 2021 | -12.38% |
| Q3 2021 | 214.39% |
| Q2 2021 | -8.40% |
| Q1 2021 | -19.94% |
| Q4 2020 | 132.40% |
| Q3 2020 | 188.56% |
| Q2 2020 | -31.68% |
| Q1 2020 | 9.70% |
| Q4 2019 | 7.60% |
| Q3 2019 | -32.75% |
| Q2 2019 | -20.92% |
| Q1 2019 | -17.92% |
| Q4 2018 | -21.73% |
| Q3 2018 | 50.58% |
| Q2 2018 | -21.92% |
| Q1 2018 | 12.08% |
| Q4 2017 | -15.45% |
| Q3 2017 | -26.39% |
| Q2 2017 | 59.91% |
| Q1 2017 | -18.54% |
| Q4 2016 | -14.73% |
| Q3 2016 | -12.62% |
| Q2 2016 | 15.46% |
| Q1 2016 | 13.10% |